Header cover image

South Korean (KOSPI) Pharma Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies98
  • 7D0.5%
  • 3M-1.5%
  • 1Y7.1%
  • YTDn/a

Over the last 7 days, the Pharma industry has risen 5.5%, driven by gains from Yuhan of 2.0%. This takes the industry's 12 month performance to a gain of 8.1%. Earnings are forecast to grow by 34% annually.

Industry Valuation and Performance

Has the South Korean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024₩50.8t₩29.4t₩922.9b16.5x55x1.7x
Sun, 24 Mar 2024₩55.5t₩30.1t₩890.9b21.4x62.3x1.8x
Tue, 20 Feb 2024₩52.2t₩29.6t₩593.1b21.1x88x1.8x
Thu, 18 Jan 2024₩51.8t₩29.6t₩592.3b22.4x87.5x1.8x
Sat, 16 Dec 2023₩50.6t₩29.6t₩588.2b21.5x86x1.7x
Mon, 13 Nov 2023₩48.3t₩29.3t₩683.4b16.7x70.7x1.6x
Wed, 11 Oct 2023₩50.4t₩29.3t₩683.3b17.1x73.7x1.7x
Fri, 08 Sep 2023₩50.1t₩29.3t₩683.9b15.9x73.3x1.7x
Sun, 06 Aug 2023₩51.8t₩28.8t₩884.1b22.2x58.6x1.8x
Tue, 04 Jul 2023₩47.5t₩28.8t₩899.2b20.7x52.8x1.6x
Thu, 01 Jun 2023₩47.5t₩28.9t₩904.9b22.9x52.5x1.6x
Sat, 29 Apr 2023₩47.7t₩28.5t₩602.7b20.9x79.1x1.7x
Mon, 27 Mar 2023₩44.1t₩28.3t₩655.8b21.6x67.2x1.6x
Wed, 22 Feb 2023₩45.5t₩27.7t₩743.5b20.6x61.1x1.6x
Fri, 20 Jan 2023₩44.9t₩28.0t₩770.2b19.7x58.3x1.6x
Sun, 18 Dec 2022₩47.7t₩28.0t₩770.2b20.1x61.9x1.7x
Tue, 15 Nov 2022₩45.0t₩27.3t₩701.8b21x64.1x1.6x
Thu, 13 Oct 2022₩40.4t₩27.2t₩694.8b19.9x58.1x1.5x
Sat, 10 Sep 2022₩47.6t₩27.5t₩725.5b21.8x65.6x1.7x
Mon, 08 Aug 2022₩52.5t₩26.7t₩475.9b23.6x110.2x2x
Wed, 06 Jul 2022₩48.6t₩26.7t₩475.9b20.5x102.2x1.8x
Fri, 03 Jun 2022₩54.2t₩26.7t₩468.1b24.5x115.8x2x
Sun, 01 May 2022₩57.0t₩26.1t₩674.3b27.3x84.5x2.2x
Tue, 29 Mar 2022₩56.6t₩25.9t₩739.5b25x76.6x2.2x
Thu, 24 Feb 2022₩53.1t₩25.0t₩934.5b23.4x56.8x2.1x
Sat, 22 Jan 2022₩54.0t₩25.0t₩934.5b22.4x57.8x2.2x
Mon, 20 Dec 2021₩61.8t₩25.0t₩934.5b26.1x66.1x2.5x
Wed, 17 Nov 2021₩61.7t₩24.7t₩872.6b27.8x70.7x2.5x
Fri, 15 Oct 2021₩64.1t₩24.7t₩876.1b24.7x73.2x2.6x
Sun, 12 Sep 2021₩71.1t₩26.0t₩960.6b38.4x74.1x2.7x
Tue, 10 Aug 2021₩72.4t₩26.0t₩960.3b40.6x75.4x2.8x
Mon, 03 May 2021₩69.3t₩24.9t₩915.5b34.8x75.7x2.8x
Price to Earnings Ratio

75.7x


Total Market Cap: ₩69.3tTotal Earnings: ₩915.5bTotal Revenue: ₩24.9tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Pharma Industry Price to Earnings3Y Average 72.6x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 55.8x which is lower than its 3-year average PE of 72.6x.
  • The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does South Korean Pharma compare with similar industries?

KR Market-0.36%
Healthcare0.63%
Pharma0.52%
Pharma0.52%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A009420 Hanall Biopharma₩34.75k8.3%
+₩134.3b
69.5%PE502.1x
A000100 Yuhan₩71.00k2.5%
+₩127.0b
29.4%PE39x
A008930 Hanmi Science₩33.35k4.2%
+₩91.5b
-23.9%PE19.6x
A039200 Oscotec₩30.20k7.7%
+₩82.1b
42.5%PS233x
A140410 Mezzion PharmaLtd₩38.25k6.3%
+₩66.8b
75.5%PS35.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A086450

₩15,940.00

DongKook Pharmaceutical

7D

-0.7%

1Y

5.9%

A000100

₩71,000.00

Yuhan

7D

2.5%

1Y

29.4%

A200670

₩31,800.00

Humedix

7D

-3.3%

1Y

12.4%

A008930

₩33,350.00

Hanmi Science

7D

4.2%

1Y

-23.9%

A140410

₩38,250.00

Mezzion PharmaLtd

7D

6.3%

1Y

75.5%

A039200

₩30,200.00

Oscotec

7D

7.7%

1Y

42.5%

A069620

₩112,400.00

Daewoong Pharmaceutical

7D

4.6%

1Y

1.8%

A354390

₩7,390.00

Baskhanbio Pharma

7D

-7.6%

1Y

18.2%